Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: preliminary evidence from the AmbOx Trial.

Jennifer A WhittyJenny RankinDina ViscaVicky TsipouriLetizia MoriLisa SpencerHuzaifa AdamaliToby M MaherNicholas S HopkinsonSurinder S BirringMorag FarquharAthol U WellsPiersante SestiniElisabetta A Renzoni

Published in: The European respiratory journal (2020)

Keyphrases

blood pressure
phase iii
study protocol
phase ii
systemic sclerosis
clinical trial
idiopathic pulmonary fibrosis
open label